The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with mosquito-borne malaria.

As resistance grows, treating severe malaria in African children becomes more challenging. Hence, new guidelines and treatment strategies are needed to combat this devastating mosquito-borne disease. Artemisinin Partial Resistance in Ugandan Children With Complicated Malaria - (https://jamanetwork.com/journals/jama/fullarticle/2826317)

The 10.3% of participants that experienced recrudescence -- recurrent malaria caused by the same strain of P. falciparum as the initial infection after treatment with artesunate followed by artemether-lumefantrine combination therapy -- was also notable John told MedPage Today.

Discover new findings on partial artemisinin resistance in Ugandan children with severe malaria. Study reveals a potential need for revised malaria treatment protocols in Africa.

A study conducted in Uganda has found evidence of partial resistance to the primary treatment for malaria in young children with severe forms of the parasitic disease.

Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with severe disease. The continent accounts for 95% of all deaths from malaria globally,